These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1732669)

  • 41. Cytogenetic as an important tool for diagnosis and prognosis for patients with hypocellular primary myelodysplastic syndrome.
    de Souza DC; Fernandez Cde S; Camargo A; Apa AG; da Costa ES; Bouzas LF; Abdelhay E; Fernandez Tde S
    Biomed Res Int; 2014; 2014():542395. PubMed ID: 25180186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
    Swolin B; Rödjer S; Westin J
    Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients.
    Haase D; Germing U; Schanz J; Pfeilstöcker M; Nösslinger T; Hildebrandt B; Kundgen A; Lübbert M; Kunzmann R; Giagounidis AA; Aul C; Trümper L; Krieger O; Stauder R; Müller TH; Wimazal F; Valent P; Fonatsch C; Steidl C
    Blood; 2007 Dec; 110(13):4385-95. PubMed ID: 17726160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytogenetic and Southern blot analysis to demonstrate clonality and to estimate prognosis in patients with myelodysplastic syndromes.
    Schmetzer HM; Poleck B; Duell T; Gerhartz HH; Mittermüller J
    Ann Hematol; 2000 Jan; 79(1):20-9. PubMed ID: 10663617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex.
    Mauritzson N; Johansson B; Rylander L; Albin M; Strömberg U; Billström R; Ahlgren T; Mikoczy Z; Mitelman F; Hagmar L; Nilsson PG
    Br J Haematol; 2001 May; 113(2):347-56. PubMed ID: 11380398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonrandom chromosomal aberrations and cytogenetic heterogeneity in gallbladder carcinomas.
    Gorunova L; Parada LA; Limon J; Jin Y; Hallén M; Hägerstrand I; Iliszko M; Wajda Z; Johansson B
    Genes Chromosomes Cancer; 1999 Dec; 26(4):312-21. PubMed ID: 10534766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myelodysplastic syndrome with chromosome 5 abnormalities: a nationwide survey in Japan.
    Tasaka T; Tohyama K; Kishimoto M; Ohyashiki K; Mitani K; Hotta T; Kanamaru A; Okamoto S; Karasawa M; Kimura A; Tomonaga M; Uchiyama T; Ozawa K;
    Leukemia; 2008 Oct; 22(10):1874-81. PubMed ID: 18668133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalities.
    Gurney M; Patnaik MM; Hanson CA; Litzow MR; Al-Kali A; Ketterling RP; Tefferi A; Gangat N
    Br J Haematol; 2017 Jul; 178(1):57-60. PubMed ID: 28419466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes.
    Jotterand M; Parlier V
    Leuk Lymphoma; 1996 Oct; 23(3-4):253-66. PubMed ID: 9031106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
    Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.
    Sanada M; Uike N; Ohyashiki K; Ozawa K; Lili W; Hangaishi A; Kanda Y; Chiba S; Kurokawa M; Omine M; Mitani K; Ogawa S
    Leukemia; 2007 May; 21(5):992-7. PubMed ID: 17315020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients.
    Li L; Liu XP; Nie L; Yu MH; Zhang Y; Qin TJ; Xiao ZJ
    Leuk Res; 2009 Sep; 33(9):1194-8. PubMed ID: 19128829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathological characteristics of myelodysplastic syndromes with del(5q) in Taiwan.
    Yang CF; Hsu CY; Hsiao LT; Chen SW; Chuang SS
    Malays J Pathol; 2023 Dec; 45(3):405-416. PubMed ID: 38155382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cytogenetic studies on 334 myelodysplastic syndrome (MDS), aplastic anemia (AA) and other hematological diseases].
    Feng BZ; Lei JL; Han JZ
    Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):754-7. PubMed ID: 7600865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
    Nimer SD
    J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytogenetic biclonality in malignant hematologic disorders.
    Furuya T; Morgan R; Sandberg AA
    Cancer Genet Cytogenet; 1992 Aug; 62(1):25-8. PubMed ID: 1521230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple unrelated clones in myelodysplastic syndrome and in acute myeloid leukemia.
    Musilová J; Michalová K; Zemanová Z; Brezinová J
    Cancer Genet Cytogenet; 1996 Jun; 88(2):141-3. PubMed ID: 8640723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Detecting chromosomal aberrations in myelodysplastic syndrome with fluorescence in situ hybridization and conventional cytogenetic analysis].
    Cao P; Li Y; Li X; Zhang G; Chen F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 39(6):605-11. PubMed ID: 25011965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Karyotypic identification of abnormal clones preceding morphological changes or occurring with no definite morphological features of myelodysplastic syndrome: a preliminary study.
    Han JY; Theil KS
    Lab Hematol; 2007; 13(1):17-21. PubMed ID: 17353178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.